Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: second revenue stream in the bag ??

As a fact, all we know(filings)is that PTSC have purchased 2 million warrants from the total 32,248,173 shares. the 25 million figure does not include the 5 million warrants still to be purchased. Until we know otherwise, S&L are still holding 30,248.173 shares. Hope this helps?

 

 

Be well

Share
New Message
Please login to post a reply